⌘K

Login Start Free

Home/Filings/4/0001127602-19-015117

4//SEC Filing

Kuyper Dirk 4

Accession 0001127602-19-015117

CIK 0000816956other

View on SEC.gov Company Profile

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 5:10 PM ET

Size

20.5 KB

Accession

0001127602-19-015117

Insider Transaction Report

Form 4

Period: 2019-04-08

CONMED CORPCNMD

Director

Transactions

Tax Payment
Common Stock
2019-04-08$82.38/sh−482$39,707→ 14,018 total
Exercise/Conversion
Sars (Stock Appreciation Rights)
2019-04-08−1,000→ 0 total
Exercise: $55.70From: 2016-06-01Exp: 2025-06-01→ Common Stock (1,000 underlying)
Tax Payment
Common Stock
2019-04-08$82.38/sh−406$33,446→ 13,500 total
Tax Payment
Common Stock
2019-04-08$82.38/sh−677$55,771→ 14,341 total
Exercise/Conversion
Common Stock
2019-04-08$39.64/sh+1,000$39,640→ 14,500 total
Sale
Common Stock
2019-04-08$83.39/sh−2,000$166,780→ 12,341 total
Exercise/Conversion
Sars (Stock Appreciation Rights)
2019-04-08−1,000→ 0 total
Exercise: $39.64From: 2015-06-01Exp: 2024-09-11→ Common Stock (1,000 underlying)
Exercise/Conversion
Sars (Stock Appreciation Rights)
2019-04-08−1,000→ 0 total
Exercise: $33.43From: 2014-06-01Exp: 2023-07-26→ Common Stock (1,000 underlying)
Exercise/Conversion
Common Stock
2019-04-08$33.43/sh+1,000$33,430→ 13,906 total
Exercise/Conversion
Common Stock
2019-04-08$55.70/sh+1,000$55,700→ 15,018 total

Footnotes (6)

[F1]The exercise reported in this Form 4 was effected pursuant to a rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
[F2]The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
[F3]The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
[F4]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
[F5]The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.
[F6]The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

CONMED CORP

CIK 0000816956

Entity typeother

Related Parties

1

filerCIK 0001404850

Filing Metadata

Form type: 4
Filed: Apr 8, 8:00 PM ET
Accepted: Apr 9, 5:10 PM ET
Size: 20.5 KB

View on SEC.gov